Achieve Life Sciences, Inc. (ACHV)

Price & Market Data

Price: $4.78

Daily Change: +$0.18 / 3.77%

Daily Range: $4.61 - $4.81

Market Cap: $481,470,976

Daily Volume: 816,594

Performance Metrics

1 Week: -15.00%

1 Month: 10.70%

3 Months: 10.44%

6 Months: 21.74%

1 Year: 54.05%

YTD: -4.42%

About Achieve Life Sciences, Inc. (ACHV)

Detailed report on Achieve Life Sciences, Inc. (ACHV). Current price: 4.78, daily change: +$0.18 / 3.77%. Market cap: 481,470,976. Explore all performance metrics.

Company Details

Employees: 28

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Canada

Details

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Selected stocks

Odysight.ai Inc. (ODYS)

Able View Global Inc. (ABLV)

Yunhong Green CTI Ltd. (YHGJ)

MFS Government Markets Income Trust (MGF)

Solowin Holdings (AXG)